Loading...
Preclinical In Vitro and In Vivo Evidence of an Antitumor Effect of CX-4945, a Casein Kinase II Inhibitor, in Cholangiocarcinoma()()()
PURPOSE: We investigated the antitumor effect of the casein kinase II (CK2) inhibitor CX-4945 on cholangiocarcinoma (CCA). METHODS: We assessed the effect of CX-4945 alone and/or in combination with gemcitabine and cisplatin on cell viability, colony formation, and apoptosis of CCA cell lines and on...
Saved in:
| Published in: | Transl Oncol |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Neoplasia Press
2018
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6187100/ https://ncbi.nlm.nih.gov/pubmed/30316146 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2018.09.005 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|